EUVIMEDEUVIMED entdecken
Editorial

Editorial on “Hypermetabolic State Drives Platelet Dysfunction in Human and Mouse Metabolic Dysfunction–Associated Steatotic Liver Disease”

Andrew L Frelinger iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 29.10.2026

DOI: 10.1161/atvbaha.126.325659 ↗

Kurz gefasst

Editorial in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, online erschienen am 29.10.2026. Verfasst von Andrew L Frelinger. Beteiligte Einrichtung: Faculty, Dana Farber/Boston Children's Cancer and Blood Disorders Center, MA (A.L.F.). Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Editorialscardiovascular diseasesfibrosisliver diseasesphospholipids

Autor:innen und Institutionen

  • Faculty, Dana Farber/Boston Children's Cancer and Blood Disorders Center, MA (A.L.F.).
  • Department of Pediatrics, Harvard Medical School, Boston, MA (A.L.F.).
  • Platelet Research Associates, LLC, North Andover, MA (A.L.F.).

ORCID-Profile: Andrew L Frelinger

Zitieren

APA

Frelinger, A. L. (2026). Editorial on “Hypermetabolic State Drives Platelet Dysfunction in Human and Mouse Metabolic Dysfunction–Associated Steatotic Liver Disease”. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.126.325659

Vancouver

Frelinger AL. Editorial on “Hypermetabolic State Drives Platelet Dysfunction in Human and Mouse Metabolic Dysfunction–Associated Steatotic Liver Disease”. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.126.325659

BibTeX
@article{Frelinger2026,
  author = {Frelinger, Andrew L},
  title = {Editorial on “Hypermetabolic State Drives Platelet Dysfunction in Human and Mouse Metabolic Dysfunction–Associated Steatotic Liver Disease”},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  doi = {10.1161/atvbaha.126.325659}
}
Kostenlos starten →